The expression of significantly hypermethylated (DISP2, MARK3, TDRD6, TRIP10, and ZNF197) or hypomethylated (ACP5, ARL8A, C1orf54, HDAC9, RAB31, and UGT3A2) sets of genes in the livers of patients with NASH was examined individually via real-time quantitative PCR (Figure S11d). The gene discussed is UGT3A2; the disease is metabolic dysfunction-associated steatohepatitis.